Cargando…

Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction that causes significant morbidity and mortality. However, the combined use of methotrexate (MTX), a synthetic disease-modifying anti-rheumatic drug (sDMARD) and biological DMARDs (bDMARDs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Hirata, Shintaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245498/
https://www.ncbi.nlm.nih.gov/pubmed/25389048
http://dx.doi.org/10.1007/s40265-014-0323-4